GiveBetter x SF

Rainbow Community Center of Contra Costa County

Finite psychotherapy access within a broad LGBTQ community organization

Research time: ~6 min on GPT-6 Astra Light
  • Research — reviewed programs, finances and impact evidence.

Published: 11 September 2026.

Funding limitations

Summary

What do they do? Rainbow provides mental-health counseling, youth/senior groups, community support, case management and sexual-health testing/navigation in Contra Costa County. Its detailed sexual-health page describes PrEP navigation and treatment referrals to public clinics. These are not verified treatment starts. The organization explicitly says it is not a crisis center. More

Why this approach interests us

  • Affirming therapy can improve symptoms for people who otherwise lack suitable care. Trainee-supported clinical delivery is an actual service, not merely outreach reach.

Our main reservations

  • The favorable 10% scenario supplies 97.75% of signed expected benefit. Annual completed courses, current capacity and incremental private funding response are unknown.

What do you get for your dollar?

The research list uses the central scenario: $38,725,116 per 10 Bay QALYs. Signed subjective mixture: $8,105,143 per 10 Bay QALYs. Central scenario: $38,725,116. This charges the whole organization but quantifies only finite psychotherapy health, not complete expected value. Inspect the model and assumptions.

whole expense
$1.273M — FY2025; all community, clinical and administrative spending retained.
bay mixture
$8,105,143 — Per 10 Bay QALYs; partial quantified health, not complete return.
central
$38,725,116 — Distinct scenario, not the signed mixture.
favorable tail
97.75% — Contribution of the 10% favorable world to signed expected health.

1. What do they do?

Rainbow provides mental-health counseling, youth/senior groups, community support, case management and sexual-health testing/navigation in Contra Costa County. Its detailed sexual-health page describes PrEP navigation and treatment referrals to public clinics. These are not verified treatment starts. The organization explicitly says it is not a crisis center.

Estimate actual therapy delivery

Use a small clinician-capacity prior anchored only loosely to the six-name trainee roster; convert attended sessions into course starters, then meaningful completed person-condition courses.

Credit finite symptom change

Apply a bounded utility-duration proxy, adjusted for local treatment differences and realistic alternative care; no suicides or HIV infections automatically prevented.

Retain whole-gift scope

All costs remain, while unquantified community, housing and sexual-health pathways remain unknown—not zero. Cash response reflects existing public-funded baseline.

Scope of this review. Only psychotherapy symptom health is quantified. Peer support, senior/youth community services, housing navigation and HIV/STI linkage may matter but lack a nonoverlapping completed-care denominator here. They are not assigned zero benefit. No program-only cost substitution, free donated labor assumption, lifetime suicide-prevention award or referral-to-treatment shortcut.

2. Monitoring and information sharing

Whole legal recipient, EIN 68-0375857

Original FY2025 Form 990. Expense $1,273,319; government revenue $1,232,945; broad program narrative with no annual completed-care count.

Our assessment. Retain whole expense. Pandemic-era text is not proof of current service volumes; food Supply Train is explicitly described as ended August 2023.

All-age clinical services and six listed trainees

Current undated official service and intern pages. Individual, couples, family and adolescent therapy; several narrative/somatic modalities.

Our assessment. Roster is not FTE or courses; modeled capacity and completion are judgments. Do not assume standardized CBT or add family members automatically.

63 young gay/bisexual men, New York City, symptomatic and not in regular care

2015 randomized immediate treatment versus three-month waitlist. Affirmative CBT pilot reported symptom and behavioral improvements.

Our assessment. Small narrow waitlist study; no QALY coefficient or Rainbow treatment-fidelity evidence. Do not generalize to all identities, ages, conditions or modalities.

254 young sexual-minority men; ESTEEM versus HIV counseling/testing or affirmative community counseling

2022 three-arm randomized trial. Primary sexual-risk outcome not significantly better; secondary mental-health comparisons did not reach significance after false-discovery correction.

Our assessment. Small-to-moderate nonsignificant advantages do not prove zero benefit, but sharply weaken claims of large added value over existing appropriate care. Supports clinical-null and alternative-care uncertainty.

212 adolescents with depression who declined/stopped antidepressants

2018 trial-based economic evaluation of CBT plus usual care versus usual care. Reported 26.8 extra depression-free days and .067 QALYs over 12 months. Simple stated .4 decrement ×26.8/365 gives .02937; reconciliation unresolved.

Our assessment. Neither figure is directly imported. Rainbow's central .06 ×.5 ×.65 = .0195 conditional Q per completed course is a judgment; youth CBT evidence does not validate local adult/family care.

Testing/navigation clients and public-clinic referrals

Detailed official HIV/STI service page. PrEP information/referrals and treatment connections; public clinic schedules and payer access listed.

Our assessment. No retained PrEP, ART or STI-treatment outcomes counted; broad clinical page wording must not override the detailed referral boundary.

3. Qualitative assessment

Affirming therapy can improve symptoms for people who otherwise lack suitable care. Trainee-supported clinical delivery is an actual service, not merely outreach reach.

Key reservations

  • Whole-cost partial-health price is not complete organization value; important unquantified pathways could change it.
  • No annual unique course denominator or observed symptom utility; roster-based capacity is weak.
  • Public funding dominates reported revenue; current private cash-created capacity is unknown.
  • The favorable 10% world drives nearly all signed expected benefit.
  • Trial methods/populations differ from local narrative/somatic, couples and family care.
  • Official site says not a crisis center; no suicide mortality credit.

Benefits not included in our estimate

  • HIV infections averted or ART retention inferred from testing/referrals
  • Suicide deaths averted or lifetime survival from routine counseling
  • Peer-group and family-member benefits added without deduplication
  • Current food-pantry benefit from discontinued Supply Train
  • Housing, social support, youth/senior wellbeing and dignity—unquantified, not zero

4. What do you get for your dollar?

$8,105,143 per 10 Bay QALYs

Weighted annual Bay health is 1.57100132; a bounded $10,000 gift produces 0.012337845583078553. Central modeled completed unique courses are 100.8, not an observed count.

A better life is our comparison unit of 10 additional quality-adjusted life years (QALYs), potentially spread across people. These are uncertain estimates, not measured returns or verified donation offers.

How we calculate the estimate

Signed finite therapy health: gift / whole expense × funding × Bay share × [unique course starters × completion × utility gain × duration × local transfer × clinical access increment − unique starters × harm]
0.012337845583078553 Bay QALYs per $10,000

Model inputs and assumptions
Whole annual expense
$1,273,319 (range: FY July 2024–June 2025). All programs and overhead retained. $1,110 depreciation and other noncash accounting entries not removed without reconciliation; not a complete economic-resource price. Filed accounting anchor.
Annual clinician equivalents
5 (range: 3–8). Six names on an undated trainee roster anchor only approximate scale. Five is not five observed FTE; eight allows other providers. Turnover and actual clinical hours unknown. Very uncertain / analyst judgment.
Attended sessions per clinician-week
8 (range: 5–12). Judgment, not a published caseload; excludes no-show appointments by definition. Very uncertain / analyst judgment.
Clinical weeks per year
40 (range: 32–44). Judgment for trainee calendar/leave; no annual throughput reported. Very uncertain / analyst judgment.
Average consumed sessions per course starter
10 (range: 8–12). Includes partial courses; not ten sessions observed per client. Trial protocols do not establish local delivery. Very uncertain / analyst judgment.
Meaningful-course completion fraction
.70 (range: .50–.85). Judgment applied to benefit only. No trial intention-to-treat estimate is multiplied by completion. Very uncertain / analyst judgment.
Distinct person-condition course fraction
.90 (range: .80–.95). Avoids treating repeat courses or couple/family encounters as additional clinical people. No multiple diagnoses added. Very uncertain / analyst judgment.
Conditional symptom utility gain
.06 (range: .03–.10 plus zero; signed diagnostics allowed). Preference-based value is an analyst proxy, not symptom-score conversion or LGBTQ identity value. Very uncertain / analyst judgment.
Finite benefit duration
.5 year (range: .25–1 year). Integrated short-term symptom benefit, not mortality or lifetime identity-related gain. Flat duration is a simplifying assumption. Very uncertain / analyst judgment.
Local modality/population transfer
.65 (range: .50–.80). Roster includes narrative/somatic approaches, not proven trial-protocol CBT. Trial populations are narrower than all ages/genders served. Very uncertain / analyst judgment.
Benefit beyond alternative care
.50 (range: .30–.70). Conditional on service delivered; other counseling/covered services may substitute. Not a second attendance discount. Very uncertain / analyst judgment.
Additional service from ordinary cash
.40 (range: 0–.65). Cash response beyond already financed public/private baseline; separate from clinical alternatives. Not proven funding room. Very uncertain / analyst judgment.
Bay benefit share
.98 (range: .95–1). Contra Costa footprint, not verified patient residences. Same fraction applied to harms. Very uncertain / analyst judgment.
Independent burden per unique starter
.001 QALY (range: 0–.005). Judgment for burdens/adverse experiences beyond clinical change; applies even to non-completers. Very uncertain / analyst judgment.
Joint subjective scenario weights
20% funding-null; 15% clinical-null; 10% harm (range: 25% cautious; 20% central; 10% favorable). Locked before first output, not empirically calibrated. No coefficient retuning. Very uncertain / analyst judgment.

$10,000 analytic illustration, not an available treatment package

  • funding_null: No positive finite price per 10; weight 0.2. Annual Bay QALYs 0; 144 modeled unique starters; 100.8 completed equivalents.
  • clinical_null: No positive finite price per 10; weight 0.15. Annual Bay QALYs 0; 144 modeled unique starters; 100.8 completed equivalents.
  • harm: No positive finite price per 10; weight 0.1. Annual Bay QALYs -0.28224; 144 modeled unique starters; 100.8 completed equivalents.
  • cautious: No positive finite price per 10; weight 0.25. Annual Bay QALYs -0.00874; 32 modeled unique starters; 16 completed equivalents.
  • central: $38,725,116 per 10; weight 0.2. Annual Bay QALYs 0.32880960000000004; 144 modeled unique starters; 100.8 completed equivalents.
  • favorable: $829,174 per 10; weight 0.1. Annual Bay QALYs 15.356483999999998; 501.59999999999997 modeled unique starters; 426.35999999999996 completed equivalents.
  • without_favorable: $324,156,279 per 10. Remaining worlds renormalized; does not retune underlying assumptions.
  • half_sessions: $16,210,286 per 10. Named diagnostic only; full inputs/results saved separately.
  • half_duration: $16,841,221 per 10. Named diagnostic only; full inputs/results saved separately.
  • half_cash: $16,210,286 per 10. Named diagnostic only; full inputs/results saved separately.
  • central_clinical_all_worlds: $31,759,148 per 10. Named diagnostic only; full inputs/results saved separately.
  • double_resources: $16,210,286 per 10. Named diagnostic only; full inputs/results saved separately.

Uncertainty. No observed annual clinical-course denominator. The six-name roster is not six full-time providers. Clinical response is a conditional analyst utility-duration proxy; it is NOT an imported intention-to-treat coefficient with a second completion penalty. Completion controls clinically meaningful course delivery; unique fraction controls repeated person-condition counting; transfer controls modality/population; access controls alternate care; funding controls cash-created delivery. These separate concepts remain empirically uncertain and correlated. Favorable-world removal raises price sharply. Subjective mass below $1M is 0.1 and below $100k is 0; these are not calibrated probabilities.

5. Funding and previous grants

HOLD giving recommendation. The central and weighted therapy-only estimates are above $1M per 10 Bay QALYs, and no priced marginal clinical capacity is verified.

FY2025 expense $1,273,319 versus prior $1,752,448. Government contributions $1,232,945 of $1,494,629 revenue (~82.5%); fees $78,930. Net assets $454,076, liabilities $351,672 and surplus $221,310 do not prove cash room or lack of need. Annual clinical throughput and allocation of public contracts are unknown. Fee revenue is not all therapy revenue. The $10,609 MSW intern stipend line does not price full therapy delivery or donated supervision. All overhead retained; donated resources/partners unpriced. No donation link offered because destination/payment verification failed despite official site navigation link.

This review does not establish a verified marginal funding offer or a complete history of grants.

We have not verified a suitable donation route for this reviewed activity. Confirm the legal recipient and intended allocation before donating.

6. Sources

  1. Original Rainbow FY2025 Form 990. IRS via ProPublica. Primary. Published: Submitted March 2, 2026; retrieved: 2026-09-11.
  2. Original FY2025 Schedule O. IRS via ProPublica. Primary. Published: Submitted March 2, 2026; retrieved: 2026-09-11.
  3. Clinical services. Rainbow Community Center. Primary. Published: Undated current page; retrieved: 2026-09-11.
  4. Clinical intern roster. Rainbow Community Center. Primary. Published: Undated current page; retrieved: 2026-09-11.
  5. HIV and STI services. Rainbow Community Center. Primary. Published: Undated current page; retrieved: 2026-09-11.
  6. Affirmative CBT pilot randomized trial. Pachankis et al.. Primary. Published: 2015; retrieved: 2026-09-11.
  7. Three-arm affirmative CBT trial. Pachankis et al.. Primary. Published: 2022; retrieved: 2026-09-11.
  8. Cost-effectiveness of CBT for depressed youth declining antidepressants. Dickerson et al.. Primary. Published: 2018; retrieved: 2026-09-11.
  9. Official donation route linked from clinical page. Rainbow Community Center. Primary. Published: Undated; retrieved: 2026-09-11.

Annual expenses: years and sources

Average annual expenses (three consecutive fiscal years): $1,732,969. Organization size is separate from the modeled cost-effectiveness of a donation.

Rainbow Community Center Of Contra Costa County

Form 990/990-EZ reported whole-entity expenses; includes program, administration and fundraising costs, but excludes any costs netted against revenue.

Latest original return and prior-year comparative combined with earlier filing data.